Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.
| Metric | CANTE | HNRG | GNE | CNA | AGL | TA | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | — | 33.16 | 12.09● | — | — | — | 25.08 |
| P/B | 0.40● | 3.64 | 0.76 | 0.64 | 1.20 | 4.33 | 1.46 |
| EV/EBITDA | 8.39 | 8.86 | 6.36 | 0.09● | 6.95 | 14.74 | 11.06 |
| P/S | 1.83 | 1.66 | 0.67 | 0.10● | 0.40 | 2.75 | 1.83 |
| Metric | CANTE | HNRG | GNE | CNA | AGL | TA | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.01● | 0.80 | 0.89 | 1.45 | 1.02 | 0.76 | 0.96 |
| Debt/Equity | 2.1%● | 3.0% | 51.9% | 92.6% | 115.8% | 317.2% | 74.5% |
| NetDebt/EBITDA | -1.09● | -0.46 | 2.49 | -0.26 | 3.32 | 5.96 | 2.77 |
| Metric | CANTE | TRCAS | IZENR | ARASE | AKSEN | Ind. Median |
|---|---|---|---|---|---|---|
| P/E | — | 7.52● | 52.02 | 11.89 | 28.86 | 25.08 |
| P/B | 0.40● | 0.65 | 1.31 | 1.34 | 1.57 | 1.46 |
| EV/EBITDA | 8.39 | — | 12.11 | 3.49● | 12.06 | 11.06 |
| P/S | 1.83 | — | 2.60 | 0.81● | 2.58 | 1.83 |
| Metric | CANTE | TRCAS | IZENR | ARASE | AKSEN | Ind. Median |
|---|---|---|---|---|---|---|
| Current Ratio | 3.01 | 36.58● | 7.58 | 2.06 | 0.63 | 0.96 |
| Debt/Equity | 2.1% | 0.0%● | 5.9% | 13.2% | 81.8% | 74.5% |
| NetDebt/EBITDA | -1.09● | 3.18 | 0.16 | 0.11 | 3.91 | 2.77 |
The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.